Mountain flora in the Kaokoveld deserve priority conservation efforts.
Articles on Endemic
Displaying all articles
The current increase in infections is not any surprise to disease scientists – nor is it anything to be too concerned about.
With the emergency phase of the COVID-19 pandemic in the rearview mirror, at least for now, we look back on a handful of stories that provided sharp insights at key moments in the pandemic.
As COVID-19 transitions from a pandemic to an endemic, apocalyptic science-fiction and zombie movies contain examples of how to adjust to the new normal.
A new generation of vaccines and boosters against SARS-CoV-2 may take a page from the anti-influenza playbook, with shots periodically tailored to target the most commonly circulating virus strains.
Repeated resurgences of SARS-CoV-2 transmission are expected in the years to come.
Endemic doesn’t mean we drop our guard, surrender to the virus or downgrade the threat the virus poses to individuals and the community.
None of our authors can see the future, but many do have expertise that offers insights about what’s reasonable to expect.
If COVID symptoms are less severe, people with the Omicron variant may be less likely to test and isolate.
At the beginning of 2020, most people hadn’t used the word ‘pandemic’ before. Now it’s time to understand the term ‘endemic’ and find out what to expect when COVID changes shape.
As ready as you are to be done with COVID-19, it’s not going anywhere soon. A historian of disease describes how once a pathogen emerges, it’s usually here to stay.
It brought panic, fear and huge pressure on healthcare. Will we get it wrong again?
An economics risk analysis offers some insight into the modern anti-vaxx movement.
Top contributors
-
Associate Professor of History, Rutgers University - Newark
-
Pediatric Infectious Diseases Fellow, University of Pittsburgh
-
Assistant Professor of History, University of Pittsburgh
-
Emeritus Professor, infectious disease ecology, Griffith University
-
Director: Modelling and Simulation Hub, Africa (MASHA), University of Cape Town
-
Associate Professor, Epidemiology, Deakin University
-
Associate Professor and Research Leader in Virology and Infectious Disease, Griffith University
-
Associate Professor Natural Resource Management, Namibia University of Science and Technology
-
Professor of Molecular, Cellular and Developmental Biology, University of Colorado Boulder
-
Microbiologist, Griffith University
-
Adjunct Professor of Epidemiology, University of Texas Health Science Center at Houston
-
Associate Professor of Epidemiology, Texas A&M University
-
Director: SACEMA, South African Centre for Epidemiological Modelling & Analysis (SACEMA)
-
Postdoctoral Fellow in Epidemiology, University of North Carolina at Chapel Hill
-
Professor of Medicine, University of East Anglia